The ADC binds Trop-2 (not topoisomerase I) on tumor cells, is internalized, and releases SN-38, which inhibits topoisomerase I to cause DNA damage and apoptosis. Topoisomerase I is the payload’s enzymatic target, not the antigen that directs cell killing.